CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

OMEZA's OCM will be featured in an approved abstract treating a complex chronic burn patient at Fall SAWC Oct.15-18 in Las Vegas

ConferenceOCMPositive
AI Analysis

Summary

OMEZA's OCM product will be featured in an approved abstract at the Fall SAWC Conference in Las Vegas (October 15-18, 2026), presenting a retrospective evaluation of OCM as primary therapy for thermal burn wounds in an adult private practice setting.

Outcome Details

Approved abstract for presentation at Fall SAWC Conference

Importance:3/10
Sentiment:
0.30
conference presentationwound careclinical abstractretrospective study

Read the original article

Published by PR Newswire Biotech on August 31, 2026 11:00 AM

Read Original